FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2012/06/002747 [Registered on: 26/06/2012] Trial Registered Retrospectively
Last Modified On: 01/05/2016
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Other 
Public Title of Study   A Study to Estimate the Prevalence of Depression in Type2 Diabetes Patients as compared to non-diabetic patients in a Tertiary Care Centre 
Scientific Title of Study   Prospective Comparative Study to Estimate the Prevalence of Depression in Type2 Diabetes Patients in a Tertiary Care Centre 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
DDM001 VERSION-1.1 DATE- 2nd May 2012  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)  
Name  Samreen Siddiqui 
Designation  Clinical Research Trainee  
Affiliation  Max Super Speciality Hospital 
Address  Clnical Research Department 2 Press Enclave Road Saket New Delhi
Endocrinology Department 2 Press Enclave Road Saket New Delhi
New Delhi
DELHI
110017
India 
Phone  9582865898  
Fax    
Email  sid_samreen@hotmail.com  
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  Samreen Siddiqui 
Designation  Clinical Research Trainee  
Affiliation  Max Super Speciality Hospital 
Address  Clnical Research Department 2 Press Enclave Road Saket New Delhi
Endocrinology Department 2 Press Enclave Road Saket New Delhi
New Delhi
DELHI
110017
India 
Phone  9582865898  
Fax    
Email  sid_samreen@hotmail.com  
 
Details of Contact Person
Public Query

Modification(s)  
Name  Samreen Siddiqui 
Designation  Clinical Research Trainee  
Affiliation  Max Super Speciality Hospital 
Address  Clnical Research Department 2 Press Enclave Road Saket New Delhi
Endocrinology Department 2 Press Enclave Road Saket New Delhi
New Delhi
DELHI
110017
India 
Phone  9582865898  
Fax    
Email  sid_samreen@hotmail.com  
 
Source of Monetary or Material Support  
Max super spciality Hospital  
 
Primary Sponsor  
Name  Max Super Speciality Hospital 
Address  2 Press enclave road saket new delhi 
Type of Sponsor  Private hospital/clinic 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sujeet Jha  Max Super Speciality Hospital  Endocrinology Department 5th Floor 2 Press Enclave Road Saket New Delhi
New Delhi
DELHI 
9910609000

sujeet.jha@maxhealthcare.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
Institutional Ethics Committee Max Super Speciality Hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Prevelance of depression in Type 2 Diabetic Patients Vs Non Diabetic patients,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  CASE GROUP
•Patients having diagnosis of type 2 diabetes as defined by American Diabetes Association (ADA 2011) criteria.
•Patients with absence of diagnosis of depression/anxiety before the diagnosis of DM.

CONTROL GROUP
•Absence of diagnosed type 2 diabetes mellitus as defined by ADA criteria (2011) 
 
ExclusionCriteria 
Details  CASE GROUP
•Associated drug and alcohol dependence.
•Presence of organic illness associated with depression.
•Any other major psychiatric illness, like Schizophrenia and mental retardation.
•Patients with severe cognitive impairment.
•Patient already on any psychotropic drug.
•Any past history of psychiatric disorder.

CONTROL GROUP
•Any past history of psychiatric disorder.
•Patients with severe cognitive impairment
 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
PRIMARY-Presence of depression in both the case and control (non-diabetic) groups at the time of assessment.

 
2 months 
 
Secondary Outcome  
Outcome  TimePoints 
SECONDARY-
1.Higher depression score in case of poor glycemic control.
2Depression is associated with diabetic neuropathy, nephropathy and diabetic foot and not associated with diabetic retinopathy

 
SECONDARY-
1.Higher depression score in case of poor glycemic control.
2Depression is associated with diabetic neuropathy, nephropathy and diabetic foot and not associated with diabetic retinopathy

 
 
Target Sample Size
Modification(s)  
Total Sample Size="260"
Sample Size from India="260" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/06/2012 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial
Modification(s)  
Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Siddiqui S, Jha S, Agarwal NB. Waghdhare S, Singh K. Prevalence of Depression in patients with Type 2 diabetes attending a Tertiary Clinic in India. Postgrad Med J Published Online First: [04 Aug 2014] doi:10.1136/postgradmedj-2014-132593.  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

The Primary purpose of the study is to estimate the prevalence of clinically relevant depression in type 2 diabetic patients as compared to non-diabetic group. and to to determine the relation of depression with glycemic control and also to determine the association of depression with co-morbid complications of T2DM.

The hypothesis being tested is:

 

      H0: pT = pC vs. H1: pT ≠ pC

 

      Where pT and pC   are the proportion of depression in diabetes and non diabetes groups respectively, rejection of the null hypothesis at a two sided significance level of 0.05 indicates a significant   difference between two arms.

 

 
Close